The effects of common peroneal nerve electrical stimulation on lower extremity deep venous hemodynamics: A randomized, crossover and controlled study Authors: Zhao-Jun Zou, Hai-Xin Song, Ting Wang, Hai-Yun Ma, Li-Ping Cao, Tao Wu Published: 2024 ABSTRACT Background:Intermittent pneumatic compression (IPC) and neuromuscular electrical stimulation can improve deep vein hemodynamics in the lower limbs. We developed a new, small and convenient, and easy to wear common peroneal nerve electrical stimulator (CPNES) and to investigate the effectiveness and safety of CPNES intervention on deep venous hemodynamics.Methods:Thirty healthy volunteers were recruited and randomly divided into group A and B. In group A, the hemodynamics of the left superficial femoral artery and the superficial femoral vein were measured after IPC compression, and then the CPNES was activated and the hemodynamics was measured again. In group B, the order of intervention was reversed.Results:In group A, the peak velocity, time average blood flow velocity (TAMV), and flow velocity of femoral vein after IPC and CPNES intervention were higher than these of the baseline (P < .05, respectively). No significant differences of these blood flow parameters were found between IPC and CPNES intervention (P > .05, respectively). In group B, these blood flow parameters of femoral vein after IPC and CPNES intervention were higher than these of the baseline (P < .05, respectively). No significant difference of these blood flow parameters (P > .05, respectively) were noted between IPC and CPNES intervention as well. No differential change of these flow velocity of femoral artery after IPC and CPNES intervention in group A or group B. The hemodynamics of superficial femoral arteries and veins after intervention in group A and B were similar (P > .05, respectively).Conclusion:The effectiveness of CPNES intervention on the hemodynamics of the lower extremity is similar with that of IPC, increasing blood flow and may prevent venous thrombosis without adverse reaction. 1. Introduction Venous thromboembolism (VTE)[1,2] is the third most common blood vessel disease. It was reported that the incidence of VTE is (104–117)/100,000 per year in the United States, (110–183)/100,000 per year in European countries, and (13–57)/100,000 per year in Asia.[3,4] It was classified into pulmonary embolism and deep venous thrombosis (DVT). DVT is a disorder of venous return caused by abnormal blood clotting in deep veins, and usually occurs in lower extremity veins. However, DVT and post-thrombotic syndrome caused by thrombosis are clinically critical diseases, which not only affect the quality of life but even cause death.[5] To prevent the DVT, physical prophylaxis has been used as a recommended method together with drug prophylaxis in DVT prevention guidelines and expert consensus in recent years.[6] However, there are few types of prevention devices that meet the clinical needs. Intermittent pneumatic compression (IPC) can improve deep vein hemodynamics in the lower limbs and prevent thrombosis.[7] However, it requires skilled staff, specific machines, and can only be used lying in bed. Recently, studies have shown that neuromuscular electrical stimulation (NMES) has the effect of increasing venous blood flow velocity in the lower extremity[8,9] and may prevent DVT in the lower extremity. However, previous devices have lacked specificity and were complex to operate. In this regard, we developed a new, small and convenient, and easy to wear common peroneal nerve electrical stimulator (CPNES). It activates the contraction of the muscle pump in the front of the leg by stimulating the common peroneal nerve, then, causing the valve in the calf vein to open, forcing the venous blood to return to the heart, and increasing the blood flow rate and achieving the goal of thrombosis prevention. The aim of this study is to investigate the effect of our new stimulator intervention on deep vein hemodynamics by compared IPC, which may reduce the incidence and mortality of DVT. We hypothesized that CNES as a new NMES device would increase femoral venous blood flow. 2. Material and methods 2.1. Trial design This is a randomized, crossover, and controlled trial. 2.2. Subjects Thirty healthy volunteers were recruited between January 2022 and December 2022. The volunteers were screened for evaluation, including medical history, physical examination, and lower extremity Doppler ultrasound to rule out thrombosis (bilateral venous ultrasound confirmed no DVT and significant venous reflux (>0.5 s). During the course of the study, 1 patient withdrew due to personal reasons, 2 patients did not complete measurement data, and 14 in group A and 13 in group B completed the study. There was no significant difference in age (28.14 ± 4.88 vs 31.53 ± 4.37 years old), body weight (49.33 ± 2.92 vs 49.83 ± 4.07 kg) between group A and group B (P > .05, respectively). Inclusive criteria: health status: healthy; sex: male; age: between 18 and 65 years old; disease history: no thrombos is or hematological diseases; body mass index: between 18 and 34 kg/m2; drugs: no history of drug abuse (including alcohol); medication: no medication was given within 30 days before this study. Exclusion criteria: health status: presence of organ dysfunction or any clinically significant deviation from normal during physical examination; disease history: have hematological disorders (including VTE), peripheral artery disease (ankle-brachial pressure index < 9), varicose veins or lower extremity ulcers, musculoskeletal disorders, surgery or recent lower extremity trauma or hematological disease within 30 days before this study; pregnancy: positive pregnancy test; medication: any medication history in the past 30 days; tobacco consumption: smokers; pulse rate < 50 times/minute; blood pressure: systolic blood pressure > 160 mm Hg or > 80 mm Hg, or diastolic blood pressure > 90 mm Hg or > 60 mm Hg; Blood donation: donates blood within 8 weeks of screening or investigation. 2.3. Randomization and masking Random numbers generated in advance by the biostatistician were placed into sequentially numbered opaque envelopes, sealed and used for subject assignment. The patients were divided into group A and B. While the therapist and patient could not be blinded, the manometry reader and the data analyst were unaware of patient assignment or previous data. Study recruitment and biofeedback treatment were performed at our hospital. All subjects provided written informed consent and this study was approved by the Ethics Committee of our hospital [20201029-30]. 2.4. Common peroneal nerve electrical stimulator (CPNES) We used our CPNES, which we developed based on the existing thrombus stimulator. The optimal position of CPNES was determined by comparative study, and the minimal information requirement of stimulation perception reconstruction was studied by physical method, the sensory feedback at the stimulus site and the encoding of the stimulus output realize the information conversion. The sensory information feedback and the generation of downlink control command of the stimulus output end are studied by using the virtual model of human shank, for effective reconstruction of the calf nerve stimulation dose and sensory feedback into a linear relationship. As improving the size of the common peroneal nerve stimulator, it is small and easy to operate, easy to wear, any posture, activity is not affected (Fig. 1). Common peroneal nerve electrical stimulator: ① Pressing the sub-button to increase the stimulation intensity, ② Pressing the sub-button to reduce the stimulation intensity. 2.5. Procedures of intervention IPC pressure and site were selected according to the literature requirements, lower leg pressure of 40 mm Hg.[10] CPNES stimulation intensity was set as 4 to 6 (the tibialis anterior muscle obvious contraction) usually as different tolerance individuality. In light of previous findings, a 20-minute interval allowed blood flow to return to baseline levels, so the 2 devices were set at a 20-minute interval when cross-referenced. For group A, after a 10-minute period of equilibrium quiescence, the baseline hemodynamics was recorded and the CPNES was activated for 20 minutes, the measurements were then repeated 20 minutes after the device was opened, closed, and stopped. Subjects were allowed a 20-minute break for cleaning. Reactivate the IPC device and get the results 20 minutes after the device is on, off and hemodynamics. For group B, our new stimulator was used with the same process of group A. 2.6. Hemodynamics measurement Use a Konica Minolta ultrasound machine and a L4-18 high frequency probe and its application in the blood flow measurement program. Subjects were semi-seated in an examination chair and allowed to adjust their position during the scan for comfort. All the ultrasound measurements came from the left leg. The left superficial femoral artery and the superficial femoral vein at the inguinal junction were identified, and the position of the probe was marked on the skin to ensure consistency of repeated measurements, with the legs rotating outward to a position of 35° to 40° on the buttocks. The knee was bent according to the comfort of the subject (Fig. 2), and the median peak velocity, the median time average maximal velocity (TAMV), and the median flow velocity were recorded. Electrode location and hemodynamics measurement. (A) The electrical stimulator was placed below the tibial tuberosity of the lower leg. (B) Real-time Doppler measurement during common peroneal nerve electrical stimulation. 2.7. Statistical analysis Data will be analyzed using SPSS V.20 (IBM) STATA V.15SE (StataCorp) or a similar statistical software. The mean ± SD was used to express the measurement data, rank sum test was used to rank the data. Data will be analyzed on an intention-to-treat basis. The Shapiro–Wilk testing will be performed to assess the distribution of the data. For categorical data, frequencies and percentages will be presented. Independent sample t test is used to compare measurement data between groups, paired sample t test is used to compare different intervention methods within groups, whereas the Mann–Whitney U test may be more desirable if the data are not normally distributed. P < .05 was statistically significant. 3. Results 3.1. Changes of superficial femoral hemodynamics after intervention In group A, the peak velocity, TAMV, and flow velocity of superficial femoral vein after IPC and CPNES were higher than these of the baseline with a significant difference (P < .05, respectively). There was no significant difference in peak velocity, TAMV, and flow velocity between IPC and CPNES intervention (P > .05, respectively). The median peak velocity, TAMV, and flow velocity of superficial femoral artery had no significant difference from the baseline (P > .05, respectively). There were no significant differences the peak velocity, TAMV, and flow velocity of superficial femoral artery between IPC and CPNES intervention (P > .05, respectively), as showed in Table 1. Table 1Comparison of parameters of superficial femoral hemodynamics before and after intervention in group A.BaselineIPC t P valueCPNES t P valueVein Peak velocity (cm/s)16.08 ± 3.8621.33 ± 4.642.46<.0525.06 ± 4.164.48<.00 TAMV (cm/s)7.61 ± 2.1411.28 ± 2.513.14<.0512.18 ± 1.794.64<.00 Flow rate (cc/min)154.33 ± 19.64231.54 ± 61.103.40<.05220.79 ± 45.013.82<.00Arteries Peak velocity (cm/s)23.76 ± 4.4922.59 ± 4.600.11>.0523.98 ± 5.720.83>.05 TAMV (cm/s)11.77 ± 2.4111.85 ± 1.640.73>.0512.31 ± 2.600.43>.05 Flow rate (cc/min)216.09 ± 66.12220.41 ± 56.840.14>.05215.30 ± 62.540.02>.05Vein represents the measured value of the femoral vein of the research subject; Arteries represent measurements of the femoral arteries of the subject; Peak velocity represents the median peak velocity of blood flow in the femoral vein or femoral artery; TAMV time averaged maximum velocity; Flow rate represents the median flow rate in the femoral vein or femoral artery.CPNES = common peroneal nerve electrical stimulator, IPC = intermittent pneumatic compression, TAMV = time average blood flow velocity. Comparison of parameters of superficial femoral hemodynamics before and after intervention in group A. Vein represents the measured value of the femoral vein of the research subject; Arteries represent measurements of the femoral arteries of the subject; Peak velocity represents the median peak velocity of blood flow in the femoral vein or femoral artery; TAMV time averaged maximum velocity; Flow rate represents the median flow rate in the femoral vein or femoral artery. CPNES = common peroneal nerve electrical stimulator, IPC = intermittent pneumatic compression, TAMV = time average blood flow velocity. In group B, the peak velocity, TAMV and flow velocity of superficial femoral vein after IPC and CPNES were higher than these of the baseline with significant difference (P < .05, respectively). However, peak velocity, TAMV, and flow velocity of superficial femoral artery had no significant change compared with the baseline (P > .05, respectively), as showed in Table 2. Table 2Comparison of parameters of superficial femoral vein hemodynamics at different time points in group B.BaselineIPC t P valueCPNES t P valueVein Peak velocity (cm/s)15.85 ± 4.3022.73 ± 6.292.99<.0523.21 ± 7.612.79<.00 TAMV (cm/s)6.95 ± 2.5610.85 ± 3.233.15<.0512.07 ± 4.383.35<.00 Flow rate (cc/min)173.80 ± 49.45246.23 ± 73.072.72<.05270.68 ± 54.324.38<.00Arteries Peak velocity (cm/s)21.31 ± 5.0126.57 ± 8.901.71>.0525.98 ± 6.041.98>.05 TAMV (cm/s)10.98 ± 2.4013.78 ± 4.191.92>.0513.63 ± 3.52.06>.05 Flow rate (cc/min)206.92 ± 92.40289.15 ± 116.841.79>.05267.43 ± 108.531.41>.05Vein represents the measured value of the femoral vein of the research subject; Arteries represent measurements of the femoral arteries of the subject; Peak velocity represents the median peak velocity of blood flow in the femoral vein or femoral artery; TAMV time averaged maximum velocity; Flow rate represents the median flow rate in the femoral vein or femoral artery.CPNES = common peroneal nerve electrical stimulator, IPC = intermittent pneumatic compression, TAMV = time average blood flow velocity. Comparison of parameters of superficial femoral vein hemodynamics at different time points in group B. Vein represents the measured value of the femoral vein of the research subject; Arteries represent measurements of the femoral arteries of the subject; Peak velocity represents the median peak velocity of blood flow in the femoral vein or femoral artery; TAMV time averaged maximum velocity; Flow rate represents the median flow rate in the femoral vein or femoral artery. CPNES = common peroneal nerve electrical stimulator, IPC = intermittent pneumatic compression, TAMV = time average blood flow velocity. Moreover, the peak velocity, TAMV, and flow velocity of superficial femoral vein were similar between group A and group B (P > .05, respectively) while the differences of these parameters of superficial femoral artery were not significant between the group A and B (P > .05, respectively). At last, we combined the data of group A and B, and found that these parameters of superficial femoral veins after CPNES and IPC were significantly higher than these of baseline (P < .05, respectively), as showed Table 3. Table 3Comparison of the femoral vein and artery in group A and group B before and after intervention.BaselineIPC t P valueCPNES t P valueVein Peak velocity, (cm/s)15.95 ± 4.0120.33 ± 6.252.57<.0522.82 ± 5.864.22<.00 TAMV (cm/s)7.23 ± 2.359.74 ± 3.302.70<.0511.25 ± 2.964.64<.00 Flow rate (cc/min)165.6 ± 40.08209.61 ± 60.192.65<.05227.8 ± 57.073.88<.00Arteries Peak velocity (cm/s)22.34 ± 4.8324.82 ± 7.341.23>.0523.01 ± 5.380.400>.05 TAMV (cm/s)11.31 ± 2.3712.67 ± 3.661.35>.0511.96 ± 2.480.816>.05 Flow rate (cc/min)210.78 ± 80.41228.62 ± 101.100.602>.05214.57 ± 84.480.142>.05Vein represents the measured value of the femoral vein of the research subject; Arteries represent measurements of the femoral arteries of the subject; Peak velocity represents the median peak velocity of blood flow in the femoral vein or femoral artery; TAMV time averaged maximum velocity; Flow rate represents the median flow rate in the femoral vein or femoral artery.CPNES = common peroneal nerve electrical stimulator, IPC = intermittent pneumatic compression, TAMV = time average blood flow velocity. Comparison of the femoral vein and artery in group A and group B before and after intervention. Vein represents the measured value of the femoral vein of the research subject; Arteries represent measurements of the femoral arteries of the subject; Peak velocity represents the median peak velocity of blood flow in the femoral vein or femoral artery; TAMV time averaged maximum velocity; Flow rate represents the median flow rate in the femoral vein or femoral artery. CPNES = common peroneal nerve electrical stimulator, IPC = intermittent pneumatic compression, TAMV = time average blood flow velocity. 3.2. The safety No adverse reaction was observed. 4. Discussion Slow blood flow is one of the high-risk factors for the formation of VTE.[7,11] Recent years, physical prophylaxis has been used in combination with pharmacologic prophylaxis as a recommendation in DVT prevention guidelines and expert consensus.[12–17] With the development of high-frequency ultrasound probes, the use of ultrasound to understand vascular anatomy and hemodynamics information provides an objective basis for the prevention of DVT in the lower extremity.[18] Our study showed that both group A and group B had an increase in baseline hemodynamics after CPNES with an index of increase similar to that of IPC. These results suggest that CPNES can accelerate the hemodynamics of superficial femoral veins in the lower extremities, thereby may benefit for preventing DVT. Arterial hemodynamics is faster than venous flow, and related studies have shown that the current leading cause of arterial thrombosis is the shedding of vegetation in rheumatic heart disease and coronary heart disease with atrial fibrillation, arteriosclerosis plaque and thrombosis can narrow the lumen.[19,20] Bad habits, such as long-term smokers, nicotine can cause damage to the lining of blood vessels, so that clotting factors are activated, and can cause arterial thrombosis. In this study, IPC and CPNES showed no significant change in blood flow velocity in the superficial femoral artery as compared with baseline values, which does not demonstrate efficacy in the prevention of superficial femoral artery thrombosis. The IPC is a commonly used device to prevent venous thrombosis, which can squeeze the venous blood and lymph periodically to speed up the blood flow by simulating the human muscle pump, prevention of blood stasis,[21] to ensure adequate blood reflux, achieve better thrombus prevention effect.[7] In this study, the peak velocity, TAMV, and flow velocity in the superficial femoral vein of the lower extremity were higher than the baseline after IPC pump use, which similar with previous report. The CPNES mainly activates the contraction of the muscle pump in the front of the shank, which promotes the opening of the valve of the shank vein, forces the blood of the vein to return to the heart, and increases the blood flow speed, for thrombosis prevention purposes. In this study, peak velocity, TAMV, and flow velocity of superficial femoral vein after the use of CPNES were higher than these of baseline. This implied that CPNES can prevent lower limb thrombosis. Moreover, there was no significant difference between CPNES and IPC, which suggested that CPNES can achieve the same effect in preventing lower extremity thrombosis as IPC. Due to medical resources and economic reasons, many patients choose to stay at home. CPNES is safe, low-cost, and can be used at home. For patients with mobility disorders who opt for home-based care, CNES may be used as an alternative to preventing blood clots. However, the sample size of this study is limited, further bigger data study is required. Considering sex is not the main influencing factor in the process of normal physiological blood flow,[22] single sex was recruited. And this was a first explorative study with the aim of investigating if the CPNES could significantly influence the femoral blood flow. Further studies are needed to determine whether the CPNES is applicable in clinical patients as a mechanical thrombus prevention. 5. Conclusion The CPNES, as a new NMES device, can improve lower limb venous hemodynamics to a certain extent, which is similar with the effect of IPC. These suggested it may helpful the preventing the formation of VTE. Acknowledgments We thank all volunteers and our research team. The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript. This study was supported by Zhejiang Province Medicine and Health Science Technology Program (2020PY051 and 2021KY747). Author contributions Conceptualization: Zhao-Jun Zou, Tao Wu. Data curation: Hai-Yun Ma. Formal analysis: Hai-Xin Song, Hai-Yun Ma, Tao Wu. Investigation: Hai-Xin Song, Ting Wang, Hai-Yun Ma, Li-Ping Cao. Methodology: Zhao-Jun Zou, Ting Wang, Li-Ping Cao, Tao Wu. Project administration: Zhao-Jun Zou, Tao Wu. Resources: Ting Wang, Hai-Yun Ma, Li-Ping Cao. Software: Hai-Xin Song, Ting Wang, Hai-Yun Ma, Li-Ping Cao. Supervision: Tao Wu. Validation: Ting Wang. Visualization: Ting Wang. Writing – original draft: Zhao-Jun Zou. Writing – review & editing: Hai-Xin Song, Tao Wu.